No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cytarabine / adverse effects
-
Cytarabine / therapeutic use
-
Daunorubicin / adverse effects
-
Daunorubicin / therapeutic use
-
Diagnosis, Differential
-
Dyspnea / chemically induced*
-
Dyspnea / diagnostic imaging
-
Female
-
Follow-Up Studies
-
Humans
-
Induction Chemotherapy*
-
Leukemia, Promyelocytic, Acute / diagnostic imaging
-
Leukemia, Promyelocytic, Acute / drug therapy*
-
Middle Aged
-
Mitoxantrone / adverse effects
-
Mitoxantrone / therapeutic use
-
Pleural Effusion / chemically induced*
-
Pleural Effusion / diagnostic imaging
-
Pulmonary Edema / chemically induced*
-
Pulmonary Edema / diagnostic imaging
-
Thioguanine / adverse effects
-
Thioguanine / therapeutic use
-
Tomography, X-Ray Computed
-
Tretinoin / administration & dosage*
-
Tretinoin / adverse effects*
Substances
-
Cytarabine
-
Tretinoin
-
Mitoxantrone
-
Thioguanine
-
Daunorubicin
Supplementary concepts
-
DAT protocol 1
-
MAC chemotherapy protocol